Non-viral DNA delivery platform Tethosome goes to Eli Lilly

Engage Biologics Inc., a preclinical biotechnology company pioneering non-viral DNA delivery, announced that it has been acquired by Eli Lilly and Company. Engage is developing the Tethosome platform, a novel non-viral DNA delivery system designed to overcome key limitations in DNA delivery, includi...